
Opinion|Videos|May 29, 2025
Nonimmune Adverse Effects: Managing Dysgeusia and Fatigue
Panelists discuss how the assessment and management of immune effector cell–associated neurotoxicity syndrome involves grading symptoms from mild to life-threatening, emphasizing the need for prompt recognition and rapid intervention to prevent progression and minimize long-term neurological damage.
Advertisement
Episodes in this series

Summary for Physicians:
Nonimmune Adverse Effects: Managing Dysgeusia and Fatigue
- Dysgeusia (altered taste):
- Common adverse effect, particularly with chemotherapy and immunotherapy
- Management:
- Recommend small, frequent meals with strong flavors (eg, citrus, mint).
- Suggest using plastic utensils to minimize taste alteration.
- Encourage good oral hygiene to reduce taste disturbances.
- Fatigue:
- Frequently reported, can be persistent and impact quality of life
- Management:
- Energy conservation techniques (eg, rest periods, prioritizing tasks)
- Exercise programs to improve stamina and reduce fatigue
- Monitor for underlying causes such as anemia or dehydration
- Address sleep hygiene and manage emotional stress
Challenges:
Both symptoms can be challenging to manage long term, requiring personalized strategies and regular assessment.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Lenvatinib/Everolimus Beats Cabozantinib in Phase 2 RCC Study
2
Pembrolizumab Combo Significantly Improves PFS/OS in Recurrent PROC
3
Atezolizumab Combo Displays Noninferior Survival in Endometrial Cancer
4
Sacituzumab Tirumotecan Improves Survival in Second-Line EGFR+ NSCLC
5